Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ravenquest Biomed Inc RVVQF

Ravenquest BioMed Inc is a Canada-based diversified cannabis company with divisions focused upon cannabis production, management services and consulting and specialized research and development. It provides integrated solutions to companies in the cannabis industry and provides growing and drying technologies, patient and genetic management systems, and security management solutions The company operates through the following segments - Consulting business and Cultivation and Sale of Medical Cannabis.


GREY:RVVQF - Post by User

Bullboard Posts
Comment by cornwallison Nov 14, 2018 9:43am
55 Views
Post# 28971285

RE:RE:RE:Takeaway message from today's news release

RE:RE:RE:Takeaway message from today's news release
hawkeye, have you done a similar timing comparison for cultivation/production licenses? I guess it's probably harder, since the application dates for existing licenses might not always be clear, even if the dates they were received on are. Maybe I missed it, but do you have a prediction for when Edmonton might get its license?
 
For the full sales license, at least we now have a concrete set of companies to watch and start dates to work with for similar comparisons.
 
The GTEC news release says Nov. 8 as the date the B2B licence was received.
 
The RQB and VGW news releases both say Nov. 9.
 
I'm curious to see how the timing will work out for B2B-to-full licensing transition.
Bullboard Posts